Sotera Health Revenue Growth Rates (SHC), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Sotera Health Company  (NASDAQ: SHC)
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare
 

SHC's Revenue Growth by Quarter and Year

Sotera Health's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/SHC/growth
https://api.csimarket.com/api/v1/companies/SHC/fundamentals
https://api.csimarket.com/api/v1/companies/SHC/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
Explore the Financial Data API
Financial API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery
Connect Your AI Assistant
How to Connect Your AI Assistant to CSIMarket MCP MCP Server
Access this full dataset via API
Free sample Full docs All endpoints
SHC Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 324.89
2nd Quarter June 321.38
1st Quarter March 279.07
FY 925.34

SHCs Annual Revenue
Sotera Health's Revenue in the fiscal year 2025 $ 1,163.53 millions
Sotera Health's Revenue in the fiscal year 2024 $ 1,100.30 millions
Sotera Health's Revenue in the fiscal year 2023 $ 1,049.16 millions
Sotera Health's Revenue in the fiscal year 2022 $ 1,003.69 millions
Sotera Health's Revenue in the fiscal year 2021 $ 931.48 millions




SHC Revenue third quarter 2026 Y/Y Growth Comment
Sotera Health Company reported Revenue growth of 4.61% year on year in the third quarter 2026, to $ 324.89 millions, this is lower than Sotera Health Company's recent average Revenue growth of 7.71%.

Looking into third quarter 2026 results within Healthcare Facilities industry 11 other companies have achieved higher Revenue growth. While Sotera Health Company' s Revenue increase of 4.61% ranks overall at the positon no. 1778 in the third quarter 2026.


SHC Revenue ( Y/Y Growth %) 2026
 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 4.61 %
2nd Quarter June 9.45 %
1st Quarter March 9.68 %
FY   -

Financial Statements
Sotera Health's third quarter 2026 Revenue $ 324.89 millions SHC's Income Statement
Sotera Health's third quarter 2025 Revenue $ 310.56 millions Quarterly SHC's Income Statement


SHC Revenue (Quarter on Quarter Growth %)

 2026
 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 1.09 %
2nd Quarter June 15.16 %
1st Quarter March -8.48 %
FY (Year on Year)   -


Back to SHC Growth rate Comparisons >> Back to SHC Growth rate Comparisons >>


Revenue third quarter 2026 Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #12
Healthcare Sector #280
Overall #1778

Revenue Y/Y Growth Statistics
High Average Low
23.61 % 7.71 % -6.83 %
(Sep 30 2024)  
Revenue third quarter 2026 Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #12
Healthcare Sector #280
Overall #1778
Revenue Y/Y Growth Statistics
High Average Low
23.61 % 7.71 % -6.83 %
(Sep 30 2024)  

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Sotera Health's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
18.75 % 2.73 % -20.22 %
(Jun 30 2021)  


SHC's III. Quarter Q/Q Revenue Comment
Sotera Health Company achieved in the III. Quarter 2026 below company average Revenue growth of 1.09% quarter on quarter, to $ 324.89 millions.

Within Healthcare Facilities industry 4 other companies have achieved higher Revenue quarter on quarter growth. While Sotera Health's Revenue growth quarter on quarter, overall rank is 622.


Revenue Q/Q Growth Company Ranking
Within: No.
Healthcare Facilities Industry #5
Healthcare Sector #112
Overall #622
Revenue Q/Q Growth Company Ranking
Within: No.
Healthcare Facilities Industry #5
Healthcare Sector #112
Overall #622
Revenue Q/Q Growth Statistics
High Average Low
18.75 % 2.73 % -20.22 %
(Jun 30 2021)  


SHC's III. Quarter Q/Q Revenue Comment
Sotera Health Company achieved in the III. Quarter 2026 below company average Revenue growth of 1.09% quarter on quarter, to $ 324.89 millions.

Within Healthcare Facilities industry 4 other companies have achieved higher Revenue quarter on quarter growth. While Sotera Health's Revenue growth quarter on quarter, overall rank is 622.


Sotera Health's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Sep 30 2026)		 12 Months Ending (Jun 30 2026) 12 Months Ending (Mar 31 2026) 12 Months Ending (Dec 31 2025) 12 Months Ending (Sep 30 2025)
Cumulative Revenue 12 Months Ending $ 1,230.25
Y / Y Revenue Growth (TTM) 6.98 %
Year on Year Revenue Growth Overall Ranking # 2371
Seqeuential Revenue Change (TTM) 1.18 %
Seq. Revenue Growth (TTM) Overall Ranking # 2469


Cumulative Revenue growth Comment
Assuming the Sotera Health's fiscal year would have ended in Sep 30 2026, Sotera Health would have reprted above average annual Revenue improvement of 6.98% year on year, of $ 1,230 millions.
This marks a slow-down of the companys growth trends and from the 8.14% growth in Jun 30 2026.

In the Healthcare sector 342 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 827 to 2371.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry # 26
Healthcare Sector # 343
Overall # 2371

Revenue TTM Y/Y Growth Statistics
High Average Low
13.85 %
 6.92 %
-0.36 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 26
Sector # 356
S&P 500 # 2469
Cumulative Revenue growth Comment
Assuming the Sotera Health's fiscal year would have ended in Sep 30 2026, Sotera Health would have reprted above average annual Revenue improvement of 6.98% year on year, of $ 1,230 millions.
This marks a slow-down of the companys growth trends and from the 8.14% growth in Jun 30 2026.

In the Healthcare sector 342 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 827 to 2371.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry # 26
Healthcare Sector # 343
Overall # 2371

Revenue TTM Y/Y Growth Statistics
High Average Low
13.85 %
6.92 %
-0.36 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 26
Sector # 356
S&P 500 # 2469




Other Revenue Growth
Healthcare Facilities Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
SHC's Revenue Growth Ratio versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue growth for the quarter ending Sep 30 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Sep 30 2026
Tactile Systems Technology Inc 8.07%$ 8.067 millions
Iqvia Holdings Inc 8.00%$ 8.000 millions
Exagen Inc 7.86%$ 7.859 millions
Gyre Therapeutics Inc 7.75%$ 7.754 millions
Stryker Corp7.64%$ 7.644 millions
Bausch and Lomb Corp7.34%$ 7.338 millions
Addus Homecare Corp7.19%$ 7.193 millions
Pacific Biosciences Of California Inc 7.03%$ 7.026 millions
Bristol myers Squibb Company6.93%$ 6.930 millions
Labcorp Holdings Inc 6.92%$ 6.917 millions
Gilead Sciences Inc 6.83%$ 6.835 millions
Arcturus Therapeutics Holdings Inc 6.68%$ 6.682 millions
National Healthcare Corp6.61%$ 6.614 millions
Tenet Healthcare Corp6.47%$ 6.466 millions
Phibro Animal Health Corporation6.32%$ 6.320 millions
Mettler toledo International Inc 6.27%$ 6.273 millions
Agilon Health Inc 5.86%$ 5.864 millions
Johnson and Johnson5.86%$ 5.860 millions
Stoke Therapeutics Inc 5.86%$ 5.860 millions
Genedx Holdings Corp 5.64%$ 5.642 millions
Adma Biologics Inc 5.59%$ 5.595 millions
Innoviva Inc 5.55%$ 5.551 millions
Universal Health Services Inc 5.30%$ 5.297 millions
Acadia Healthcare Company Inc 5.14%$ 5.136 millions
Lumexa Imaging Holdings Inc 5.03%$ 5.032 millions
Bio techne Corp4.75%$ 4.753 millions
Merck and Co Inc 4.68%$ 4.683 millions
Davita Inc 4.62%$ 4.617 millions
Sotera Health Company4.61%$ 4.613 millions
Avantor Inc 4.59%$ 4.588 millions


About Sotera Health Revenue Growth Rates (SHC), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Sotera Health Co (CIK 1822479).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001822479-26-000058
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Sotera Health Co’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.